The pharmaceutical industry is facing high clinical development costs and declining drug discovery success rates. To stay competitive companies are re-evaluating their drug development process to reduce attrition rates. Biomarkers promise to transform drug discovery, clinical development and diagnostics in the R&D process as effective use of biomarkers at each stage of R&D can improve decision-making, increase clinical trial success rates and productivity. The 8th Annual Biomarkers Congress 2013 presented by Oxford Global Conferences provides a first class educational and networking opportunity for over 250 attendees to gain knowledge and insights into the Biomarkers marketplace. Do not miss out on the opportunity to learn how you can streamline your R&D process and identify potential cost savings through successful biomarker discovery, validation and clinical development.